Finance

Lists
CONCORDBIO:NSE
Concord Biotech Ltd
1 341,50 ₹
-0,87%
(-11,80) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CONCORDBIO...
Open
1 362,90 ₹
High
1 366,80 ₹
Low
1 332,00 ₹
Mkt. cap
140,34 млрд
Avg. vol.
131,96 м.
Volume
45,38 мың
Dividend
0,56%
Quarterly dividend
1,89 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
50,99
52-wk high
1 615,00 ₹
52-wk low
987,00 ₹
EPS
26,31 ₹
No. of employees
2 мың
Open
1 362,90 ₹
High
1 366,80 ₹
Low
1 332,00 ₹
Mkt. cap
140,34 млрд
Avg. vol.
131,96 м.
Volume
45,38 мың
Dividend
0,56%
Quarterly dividend
1,89 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
50,99
52-wk high
1 615,00 ₹
52-wk low
987,00 ₹
EPS
26,31 ₹
No. of employees
2 мың
News stories
From web sources and news partners
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide. It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd
CEO-
Employees1,62 мың
Founded2000
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 03 там.
Fiscal period
Q1 2027
5,52 ₹ / 5,60 ₹
-1,43%miss
Revenue / Est. (INR)
2,57 млрд / 2,45 млрд
+5,05%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
2,47 млрд
2,78 млрд
3,26 млрд
2,57 млрд
Cost of goods sold
775,44 млн
941,71 млн
1,32 млрд
890,11 млн
Cost of revenue
775,44 млн
941,71 млн
1,32 млрд
890,11 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
444,56 млн
467,81 млн
477,71 млн
436,38 млн
Operating expense
994,14 млн
1,03 млрд
837,11 млн
1,04 млрд
Total operating expenses
1,77 млрд
1,98 млрд
2,16 млрд
1,93 млрд
Operating income
701,00 млн
802,34 млн
1,10 млрд
642,76 млн
Other non operating income
133,52 млн
99,76 млн
-356,29 млн
128,26 млн
EBT including unusual items
856,84 млн
861,56 млн
1,14 млрд
783,43 млн
EBT excluding unusual items
856,84 млн
894,31 млн
929,35 млн
783,43 млн
Income tax expense
226,21 млн
225,14 млн
256,08 млн
206,46 млн
Effective tax rate
26,40%
26,13%
22,45%
26,35%
Other operating expenses
365,67 млн
378,34 млн
163,96 млн
424,64 млн
Net income
635,81 млн
644,77 млн
887,90 млн
585,26 млн
Net profit margin
25,74%
23,21%
27,23%
22,73%
Earnings per share
6,03
6,31
8,46
5,52
Interest and investment income
-
-
24,63 млн
-
Interest expense
-591,00 м.
-815,00 м.
-840,00 м.
-364,00 м.
Net interest expenses
-591,00 м.
-815,00 м.
23,79 млн
-364,00 м.
Depreciation and amortization charges
183,92 млн
187,47 млн
195,44 млн
181,00 млн
EBITDA
881,84 млн
933,85 млн
1,28 млрд
824,23 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары